← FDA Drug Approvals (Drugs@FDA)

BUTALBITAL AND ACETAMINOPHEN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: QUAGEN · Approved 2024-02-01

Drug application

FDA Application #

ANDA214305

Application type

Abbreviated New Drug Application (Generic)

Brand name

BUTALBITAL AND ACETAMINOPHEN

Generic name

BUTALBITAL AND ACETAMINOPHEN

Active ingredients

ACETAMINOPHEN; BUTALBITAL

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

QUAGEN

Manufacturer

QUAGEN PHARMACEUTICALS LLC

First approval

2024-02-01

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown